About Asterion
Established in 2001, as a spin-out resulting from University of Sheffield’s world renowned life sciences research, Asterion engineers hormone agonists and antagonists to provide therapies for disease states that include cancer, rheumatoid arthritis and diabetes.
- Focus : Manufacturer
- Industry : Biotechnology
Product portfolio of Asterion
Similar companies
News about Asterion
Here you will find Asterion Ltd.
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
